news

July 28 2014
Advaxis Receives Notice of Allowance for Cancer Immunotherapies Patent in Japan

July 22 2014
Galena Biopharma Enters Into Definitive Agreement to License U.S. Rights for Zuplenz (ondansetron) Oral Soluble Film

July 22 2014
Advaxis and MedImmune Partner on Immuno-Oncology Combination Clinical Trial

 

events

 

spotlight